MOSAIC ONCOLOGY AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: SS
Solveig Stråtveit1971
Chairman of the board: DS
Dagfinn Steinar Øgreid1956
Years since formation: 8 years; since Apr 15, 2016
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 90,000; 1 share class
Total number of shareholders: 3; 2 companies, 1 person

Financials

Total operating income 2023: 1,668,562; NOK
Annual total result 2023: -19,736; NOK
Total equity 2023: 38,706; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
SS Solveig Stråtveit 1971	Managing Director/CEO	33.33 % directly

Board

Name	Role	Shares
DS Dagfinn Steinar Øgreid 1956	Chairman	33.33 % indirectly
SA Simen Andre Aarsland Øgreid 1991	Board Member	33.33 % indirectly
SS Solveig Stråtveit 1971	Board Member	33.33 % directly

Top 10 individual shareholders

Name	Role	Shares
DS Dagfinn Steinar Øgreid 1956	Chairman	33.33 % indirectly
SA Simen Andre Aarsland Øgreid 1991	Board Member	33.33 % indirectly
SS Solveig Stråtveit 1971	Managing Director/CEO, Board Member	33.33 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
B BAMSIC AS	Ordinary shares	30,000	33.33 %
C CITRON AS	Ordinary shares	30,000	33.33 %
SS Solveig Stråtveit 1971	Ordinary shares	30,000	33.33 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	1,668,562	1,865,762	2,582,255
Annual Total Result	-19,736	-113,978	-613,094
Total assets	48,662	284,177	542,787
Total liabilities	9,955	225,735	370,366
Total equity	38,706	58,442	172,421

P&L

Year	2023	2022	2021
Total operating income	1,668,562	1,865,762	2,582,255
Total operating costs	1,685,961	1,977,857	3,294,813
Operating result	-17,399	-112,095	-712,558
Financial income/costs	-2,337	-1,883	-24
Profit before tax	-19,736	-113,978	-712,582
Total tax & extraordinary income/cost	0	0	-99,488
Annual Total Result	-19,736	-113,978	-613,094

Balance overview

Year	2023	2022	2021
Total fixed assets	14,684	31,135	46,677
Total current assets	33,978	253,042	496,110
Total assets	48,662	284,177	542,787
Short term debt	9,955	225,735	370,366
Long term debt	0	0	0
Total liabilities	9,955	225,735	370,366
Contributed capital	90,000	90,000	90,000
Retained earnings	-51,294	-31,558	82,421
Total equity	38,706	58,442	172,421
Total equity and liabilities	48,661	284,177	542,787

MOSAIC ONCOLOGY AS917 032 637